Oncology Activities

The Growing Role of the Pharmacist in the Evolution of Immune Checkpoint Inhibitors for the Treatment of GI Cancers

0290-0000-20-087-L01-P

This virtual symposium will review biomarkers useful for predicting patient response to immune checkpoint inhibitors and techniques for adherence monitoring will also be addressed to assist pharmacists in developing strategies to optimize the care and management of patients with GI cancers.

5-21-2020

1.50

Clinical Conversations Between an Oncology Nurse and Oncology Pharmacist During the Treatment of Patients With Breast Cancer: A Focus on Oral Chemotherapeutic Formulations

0290-9999-20-068-L01-P

This live virtual symposium provides a collaborative discussion for oncology pharmacists and nurses to examine clinical updates and best practices for managing oral oncolytics in patients with breast cancer.

5-14-2020

1.50

An American Journal of Managed Care Supplement: Managed Care Considerations for Navigating Biosimilar and HER2-Directed Therapies for the Treatment of HER2-Positive Breast Cancer

0290-0000-20-062-H03-P

This supplement will identify challenges to evidence-based adoption of trastuzumab biosimilars and other HER2-targeted therapies.

2.00

Idiopathic Pulmonary Fibrosis Management: The Role of the Specialty Pharmacist

0290-0000-20-054-L01-P

This live webinar will provide specialty pharmacists with crucial counseling points regarding the management of treatment expectations as well as the importance of medication adherence to improve outcomes of patients with IPF.

4-15-2020

1.00